Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Emerging Regimens for H. pylori Infection Should Enhance Efficacy and Circumvent Resistance.

Howden CW.

Dig Dis Sci. 2019 Oct;64(10):2691-2692. doi: 10.1007/s10620-019-05747-8. No abstract available.

PMID:
31346952
2.

Reply.

Harris MS, Howden CW.

Gastroenterology. 2019 Sep;157(3):894. doi: 10.1053/j.gastro.2019.07.010. Epub 2019 Jul 12. No abstract available.

PMID:
31306632
3.

Innovative Trial Designs in GI Drug Development: Why Trials Succeed and Fail-A Brief Report From 2018 Digestive Disease Week.

Harris MS, Howden CW.

Gastroenterology. 2019 Apr;156(5):1239-1242. doi: 10.1053/j.gastro.2019.01.001. Epub 2019 Jan 6. No abstract available.

PMID:
30625298
4.

A Message from the Editors.

Rhodes JM, Howden CW.

Aliment Pharmacol Ther. 2019 Jan;49(1):4-5. doi: 10.1111/apt.15067. No abstract available.

PMID:
30548316
5.

Clarifying the Houston Consensus on Helicobacter pylori.

Chey WD, Howden CW, Leontiadis GI.

Clin Gastroenterol Hepatol. 2018 Dec;16(12):2003-2004. doi: 10.1016/j.cgh.2018.07.024. No abstract available.

PMID:
30454936
6.

On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.

Khan Z, Alastal Y, Khan MA, Khan MS, Khalil B, Shrestha S, Kamal F, Nawras A, Howden CW.

Gastroenterol Res Pract. 2018 Aug 12;2018:6417526. doi: 10.1155/2018/6417526. eCollection 2018. Review.

7.

The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.

Ali Khan M, Howden CW.

Gastroenterol Hepatol (N Y). 2018 Mar;14(3):169-175.

8.

H. pylori and Barrett's Esophagus: Implications for Populations and Practice.

Howden CW.

Am J Gastroenterol. 2018 Aug;113(8):1119-1120. doi: 10.1038/s41395-018-0135-3. Epub 2018 Jun 19.

PMID:
29915403
9.

Correction: ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2018 Jul;113(7):1102. doi: 10.1038/s41395-018-0132-6.

PMID:
29895984
10.

Proton pump inhibitors and oesophageal cancer: Flawed methodology and false alarms.

Leontiadis GI, Ford AC, Howden CW.

Cancer Epidemiol. 2018 Jun;54:137-138. doi: 10.1016/j.canep.2018.04.002. Epub 2018 Apr 17. No abstract available.

PMID:
29678411
11.

The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.

Kamal F, Khan MA, Molnar MZ, Howden CW.

J Clin Gastroenterol. 2018 Jul;52(6):468-476. doi: 10.1097/MCG.0000000000001035.

PMID:
29668562
12.

Unusual Presentation of Duodenal Ulcer Presenting with Duodenal Intussusception.

Lingala S, Moore A, Kadire S, Shankar S, Das K, Howden CW.

ACG Case Rep J. 2018 Mar 28;5:e25. doi: 10.14309/crj.2018.25. eCollection 2018.

13.

Response to Marlicz et al.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2018 May;113(5):781. doi: 10.1038/s41395-018-0034-7. Epub 2018 Mar 9. No abstract available.

PMID:
29523865
14.

Meeting Report: AGA Biosimilars Roundtable.

Howden CW, Lichtenstein GR.

Gastroenterology. 2018 Apr;154(5):e1-e5. doi: 10.1053/j.gastro.2018.03.002. Epub 2018 Mar 3. No abstract available.

PMID:
29510132
15.

Inpatient Outcomes for Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.

Cholankeril G, Hu M, Cholankeril R, Khan MA, Gadiparthi C, Yoo ER, Perumpail RB, Nair S, Howden CW.

J Clin Gastroenterol. 2019 Feb;53(2):120-126. doi: 10.1097/MCG.0000000000000971.

PMID:
29351155
16.

Response to Hsu et al.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2018 Jan;113(1):143. doi: 10.1038/ajg.2017.401. No abstract available.

PMID:
29311737
17.

Rifaximin for the prevention of spontaneous bacterial peritonitis and hepatorenal syndrome in cirrhosis: a systematic review and meta-analysis.

Kamal F, Khan MA, Khan Z, Cholankeril G, Hammad TA, Lee WM, Ahmed A, Waters B, Howden CW, Nair S, Satapathy SK.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1109-1117. doi: 10.1097/MEG.0000000000000940. Review.

PMID:
28763340
18.

Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Sep;112(9):1484. doi: 10.1038/ajg.2017.238. Epub 2017 Aug 1. No abstract available.

PMID:
28762378
19.

Response to Georgopoulos et al.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2017 Jul;112(7):1169-1170. doi: 10.1038/ajg.2017.127. No abstract available.

PMID:
28725080
20.

Proton pump inhibitors and chronic kidney disease.

Kamal F, Khan MA, Howden CW.

Kidney Int. 2017 Aug;92(2):515. doi: 10.1016/j.kint.2017.04.037. No abstract available.

PMID:
28709604
21.

ACG and CAG Clinical Guideline: Management of Dyspepsia.

Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N.

Am J Gastroenterol. 2017 Jul;112(7):988-1013. doi: 10.1038/ajg.2017.154. Epub 2017 Jun 20. Review. Erratum in: Am J Gastroenterol. 2017 Sep;112(9):1484.

PMID:
28631728
22.

Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.

Kamal S, Khan MA, Seth A, Cholankeril G, Gupta D, Singh U, Kamal F, Howden CW, Stave C, Nair S, Satapathy SK, Ahmed A.

Am J Gastroenterol. 2017 Oct;112(10):1495-1505. doi: 10.1038/ajg.2017.170. Epub 2017 Jun 6. Review.

PMID:
28585556
23.

White Paper AGA: Functional Dyspepsia.

Vakil NB, Howden CW, Moayyedi P, Tack J.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1191-1194. doi: 10.1016/j.cgh.2017.05.013. Epub 2017 May 18.

PMID:
28529164
24.

Complications of Proton Pump Inhibitor Therapy.

Vaezi MF, Yang YX, Howden CW.

Gastroenterology. 2017 Jul;153(1):35-48. doi: 10.1053/j.gastro.2017.04.047. Epub 2017 May 19. Review.

PMID:
28528705
25.

Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?

Khan MA, Cholankeril G, Howden CW.

Gastroenterology. 2017 Jun;152(8):2076. doi: 10.1053/j.gastro.2016.10.050. Epub 2017 May 4. No abstract available.

PMID:
28478154
26.

Open vs Intact Proton Pump Inhibitor Capsules for Treatment of Marginal Ulcers.

Howden CW.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1479-1480. doi: 10.1016/j.cgh.2017.03.035. Epub 2017 Apr 2. No abstract available.

PMID:
28377070
27.

Upper Gastrointestinal Toxicity Associated With Long-Term Aspirin Therapy: Consequences and Prevention.

Lavie CJ, Howden CW, Scheiman J, Tursi J.

Curr Probl Cardiol. 2017 May;42(5):146-164. doi: 10.1016/j.cpcardiol.2017.01.006. Epub 2017 Feb 1. Review.

28.

American Gastroenterological Association Drug Development Conferences: A Model for Future Collaborations.

Howden CW, Vakil NB.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1195-1196. doi: 10.1016/j.cgh.2017.02.035. Epub 2017 Mar 12. No abstract available.

PMID:
28300692
29.

Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial.

Saito YA, Locke GR, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR, Talley NJ.

Am J Gastroenterol. 2017 Jun;112(6):903-909. doi: 10.1038/ajg.2017.52. Epub 2017 Mar 14.

PMID:
28291238
30.

Does Urgent Colonoscopy Improve Outcomes in the Management of Lower Gastrointestinal Bleeding?

Seth A, Khan MA, Nollan R, Gupta D, Kamal S, Singh U, Kamal F, Howden CW.

Am J Med Sci. 2017 Mar;353(3):298-306. doi: 10.1016/j.amjms.2016.11.007. Epub 2016 Nov 8. Review.

PMID:
28262219
31.

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO.

Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6. Review.

32.

Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.

Howden CW, Vakil NB.

Gastroenterology. 2017 Mar;152(4):e1-e4. doi: 10.1053/j.gastro.2017.01.034. Epub 2017 Jan 29. No abstract available.

PMID:
28147223
33.

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Chey WD, Leontiadis GI, Howden CW, Moss SF.

Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10. Erratum in: Am J Gastroenterol. 2018 Jul;113(7):1102.

PMID:
28071659
34.

Meta-analysis of the performance of ultrathin vs. standard colonoscopes.

Sofi AA, Nawras A, Khan MA, Howden CW, Lee WM.

Endoscopy. 2017 Apr;49(4):351-358. doi: 10.1055/s-0042-117110. Epub 2016 Nov 16. Review.

PMID:
27852099
35.

Proton Pump Inhibitors and Risk of Rhabdomyolysis.

Duncan SJ, Howden CW.

Drug Saf. 2017 Jan;40(1):61-64. doi: 10.1007/s40264-016-0473-2. Review.

PMID:
27838824
36.

Response to Dai et al.

Khan MA, Howden CW.

Am J Gastroenterol. 2016 Nov;111(11):1657-1658. doi: 10.1038/ajg.2016.413. No abstract available.

PMID:
27808135
37.

Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.

Khan MA, Cholankeril G, Howden CW.

Hepatology. 2017 Jan;65(1):393. doi: 10.1002/hep.28858. Epub 2016 Nov 15. No abstract available.

PMID:
27688049
38.

Mesalamine Does Not Help Prevent Recurrent Acute Colonic Diverticulitis: Meta-Analysis of Randomized, Placebo-Controlled Trials.

Khan MA, Ali B, Lee WM, Howden CW.

Am J Gastroenterol. 2016 Apr;111(4):579-81. doi: 10.1038/ajg.2016.24. No abstract available.

PMID:
27125717
39.

Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis.

Khan MA, Kamal S, Khan S, Lee WM, Howden CW.

Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1327-36. doi: 10.1097/MEG.0000000000000448. Review.

PMID:
26313401
40.

Letter: possible association between PPI use and spontaneous bacterial peritonitis.

Khan MA, Howden CW.

Aliment Pharmacol Ther. 2015 Sep;42(6):778-9. doi: 10.1111/apt.13311. No abstract available.

41.

Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.

Talley NJ, Locke GR, Saito YA, Almazar AE, Bouras EP, Howden CW, Lacy BE, DiBaise JK, Prather CM, Abraham BP, El-Serag HB, Moayyedi P, Herrick LM, Szarka LA, Camilleri M, Hamilton FA, Schleck CD, Tilkes KE, Zinsmeister AR.

Gastroenterology. 2015 Aug;149(2):340-9.e2. doi: 10.1053/j.gastro.2015.04.020. Epub 2015 Apr 25.

42.
43.

Update on the Diagnosis and Management of Helicobacter pylori Infection in Adults.

Patel KA, Howden CW.

J Clin Gastroenterol. 2015 Jul;49(6):461-7. doi: 10.1097/MCG.0000000000000318. Review.

PMID:
25811119
44.

PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.

Howden CW.

Aliment Pharmacol Ther. 2014 Dec;40(11-12):1367. doi: 10.1111/apt.12982. No abstract available.

45.

Editorial: healing of refractory reflux oesophagitis--an ongoing unmet clinical need; authors' reply.

Kahrilas PJ, Persson T, Denison H, Wernersson B, Hughes N, Howden CW.

Aliment Pharmacol Ther. 2014 Oct;40(8):989. doi: 10.1111/apt.12943. No abstract available.

46.

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Kahrilas PJ, Persson T, Denison H, Wernersson B, Hughes N, Howden CW.

Aliment Pharmacol Ther. 2014 Sep;40(6):648-56. doi: 10.1111/apt.12877. Epub 2014 Jul 15.

47.

Economic evaluations of gastroesophageal reflux disease medical management.

Gawron AJ, French DD, Pandolfino JE, Howden CW.

Pharmacoeconomics. 2014 Aug;32(8):745-58. doi: 10.1007/s40273-014-0164-8. Review.

48.

Response to Nahon et al. and Marmo et al.

Leontiadis GI, Molloy-Bland M, Moayyedi P, Howden CW.

Am J Gastroenterol. 2013 Sep;108(9):1534-5. doi: 10.1038/ajg.2013.195. No abstract available.

PMID:
24005353
49.

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.

Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW.

Gut. 2014 May;63(5):720-6. doi: 10.1136/gutjnl-2013-304883. Epub 2013 Jul 5.

50.

Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.

Neumann I, Letelier LM, Rada G, Claro JC, Martin J, Howden CW, Yuan Y, Leontiadis GI.

Cochrane Database Syst Rev. 2013 Jun 12;(6):CD007999. doi: 10.1002/14651858.CD007999.pub2. Review.

PMID:
23760821

Supplemental Content

Loading ...
Support Center